| 2018 Korean Guideline of Atrial Fibrillation Management |
24 |
| The Past, Present and Future of Heart Transplantation |
15 |
| Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014 |
14 |
| Cardioprotective Potential of an SGLT2 Inhibitor Against Doxorubicin-Induced Heart Failure |
14 |
| Trends, Characteristics, and Clinical Outcomes of Patients Undergoing Percutaneous Coronary Intervention in Korea between 2011 and 2015 |
11 |
| Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer |
9 |
| The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and Asian Paradox |
9 |
| Management of Coarctation of The Aorta in Adult Patients: State of The Art |
9 |
| Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients |
9 |
| Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atria Fibrillation |
8 |
| Development and Validation of Deep-Learning Algorithm for Electrocardiography-Based Heart Failure Identification |
8 |
| Assessing Accuracy of Wrist-Worn Wearable Devices in Measurement of Paroxysmal Supraventricular Tachycardia Heart Rate |
8 |
| Current Management of In-Stent Restenosis |
7 |
| Acute Pulmonary Embolism: Focus on the Clinical Picture |
7 |
| Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal |
6 |
| Risk Factor Management for Atrial Fibrillation |
6 |
| Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway |
6 |
| KSHF Guidelines for the Management of Acute Heart Failure: Part I. Definition, Epidemiology and Diagnosis of Acute Heart Failure |
6 |
| Gender-related Differences in Management of Nonvalvular Atrial Fibrillation in an Asian Population |
6 |
| Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study |
6 |
| Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome |
5 |
| Trends and Outcomes of Transcatheter Aortic Valve Implantation (TAVI) in Korea: the Results of the First Cohort of Korean TAVI Registry |
5 |
| Optimization of Percutaneous Coronary Intervention Using Optical Coherence Tomography |
5 |
| Temporal and Geospatial Trends of Hypertension Management in Korea: a Nationwide Study 2002-2016 |
5 |
| Clinical Pearls of Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock |
5 |
| Metabolic Syndrome in Adult Congenital Heart Disease |
5 |
| Ideal Target Blood Pressure in Hypertension |
5 |
| Left Atrial Appendages Occlusion: Current Status and Prospective |
5 |
| Prevalence of Non-valvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population |
4 |
| Aortic Stenosis and Transcatheter Aortic Valve Implantation: Current Status and Future Directions in Korea |
4 |
| A Genetic Risk Score for Atrial Fibrillation Predicts the Response to Catheter Ablation |
4 |
| Coronary Artery Vasospasm |
4 |
| Diagnosis and Management of Isolated Superior Mesenteric Artery Dissection: A Systematic Review and Meta-Analysis |
4 |
| Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes |
4 |
| Exercise induced Right Ventricular Fibrosis is Associated with Myocardial Damage and Inflammation |
4 |
| The J-curve between Diastolic Blood Pressure and Risk of All-cause and Cardiovascular Death |
4 |
| Understanding Vulnerable Plaques: Current Status and Future Directions |
4 |
| The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry |
4 |
| Clinical Significance and Therapeutic Implication of Nocturnal Hypertension: Relationship between Nighttime Blood Pressure and Quality of Sleep |
3 |
| Tachycardia induced Cardiomyopathy |
3 |
| Unsolved Questions on the Anatomy of the Ventricular Conduction System |
3 |
| Left Ventricular Ejection Fraction Predicts Poststroke Cardiovascular Events and Mortality in Patients without Atrial Fibrillation and Coronary Heart Disease |
3 |
| Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea |
3 |
| Risk Scoring System to Assess Outcomes in Patients Treated with Contemporary Guideline-Adherent Optimal Therapies after Acute Myocardial Infarction |
3 |
| Understanding the Coronary Bifurcation Stenting |
3 |
| Acute Heart Failure Management |
3 |
| KSHF Guidelines for the Management of Acute Heart Failure: Part II. Treatment of Acute Heart Failure |
3 |
| Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013-2015 (KNHANES VI) |
3 |
| The Past, Present and Future of Cardiac Resynchronization Therapy |
3 |
| Significance of Differential Characteristics in Infantile Kawasaki Disease |
3 |
